Real-world treatment patterns, survival outcomes, and health care resource utilization (HCRU) for locally advanced or metastatic urothelial carcinoma (la/mUC) in Spain.

Authors

Javier Puente

Javier Puente

Medical Oncology Department, Hospital Clínico San Carlos, Instituto de Investigación Sanitaria del Hospital Clínico San Carlos (IdISSC), CIBERONC, Madrid, Spain

Javier Puente , Alvaro Pinto , Maria Jose Mendez Vidal , Xavier Garcia del Muro , Pablo Maroto-Rey , Sergio Vazquez-Estevez , Raquel Luque , Urbano Anido , Torsten Strunz-McKendry , Anil Upadhyay , Jose Montes , Aurora Ortiz Nuñez , Judit González Portela , Daniel Castellano

Sign-In to See More Abstracts, Journal Articles, Posters, Videos and Slides and to Bookmark Your Favorite Content.

Disclaimer

This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org

Poster Details

Meeting

2023 ASCO Genitourinary Cancers Symposium

Session Type

Poster Session

Session Title

Poster Session B: Prostate Cancer and Urothelial Carcinoma

Track

Urothelial Carcinoma,Prostate Cancer - Advanced

Sub Track

Quality of Care/Quality Improvement and Real-World Evidence

Citation

J Clin Oncol 41, 2023 (suppl 6; abstr 463)

DOI

10.1200/JCO.2023.41.6_suppl.463

Abstract #

463

Poster Bd #

H4

Abstract Disclosures

Similar Posters